Product Name: Edoxaban
CAS No.: 912273-65-5

Purity: 99%
Molecular Formula: C24H30ClN7O4S
Molecular Weight: 548.06
Appearance: White powder

SMILES: O=C(NC1=NC=C(Cl)C=C1)C(NC2C(NC(C(S3)=NC4=C3CN(C)CC4)=O)CC(C(N(C)C)=O)CC2)=O

Storage Conditions: 2–8°C

Product Description:
Edoxaban (Chemical name: N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)oxamide; the tosylate salt is used in formulations) is a small-molecule oral anticoagulant developed by the Japanese company Daiichi Sankyo.

Mechanism of Action:
Acts as a coagulation factor Xa (FXa) inhibitor. During the coagulation process, activated coagulation factor X (FXa) converts prothrombin (FII) into thrombin (FIIa), promoting fibrin formation and subsequent thrombus formation. Consequently, FXa has become a primary target for the development of next-generation anticoagulants.

Supply Capacity: kg scale available

Applications:
- Pharmaceutical research
- Anticoagulant research
- Drug development
- Cardiovascular research
- Clinical research

Product Category: Pharmaceutical Intermediates / APIs / Cardiovascular Drugs

Keywords: 912273-65-5, Edoxaban, Factor Xa inhibitor, Anticoagulant, Daiichi Sankyo

Features:
- Small-molecule oral anticoagulant
- Coagulation factor Xa (FXa) inhibitor
- Next-generation anticoagulant
- Developed by Daiichi Sankyo

Storage: 2–8°C

Note: For research and development purposes only. Not for human consumption.

Product Classification:
- APIs
- Cardiovascular Drugs
- Anticoagulants
- Pharmaceutical Intermediates

Safety Information:
For research use only. Handle with appropriate precautions.